Title : Lithium Inhibits GSK3β and Augments GluN2A Receptor Expression in the Prefrontal Cortex.

Pub. Date : 2018

PMID : 29449801






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lithium, a clinically relevant drug commonly prescribed as a mood stabilizer for psychiatric disorders, significantly increased levels of phosphorylated GSK3beta serine 9, an inhibitory phosphorylation site, and decreased beta-catenin ser33/37/thr41 phosphorylation in vitro, indicating GSK3beta inhibition and reduced beta-catenin degradation. Serine glycogen synthase kinase 3 beta Homo sapiens
2 Similar alterations were also demonstrated in vivo; lithium administration increased GSK3beta serine 9 phosphorylation and GluN2A levels, suggesting a reduced GSK3beta activity and augmented GluN2A expression. Serine glycogen synthase kinase 3 beta Homo sapiens